Number of Shares
138,000.00
Current Holdings Value*
$2.47 Mil
% of Portfolio
2.15%
Total Estimate Gain
$1.72 Mil
% of Total Estimate Gain
46.55%

Birchview Capital, LP's Travere Therapeutics Inc Holding Summary

As of 2025-03-31, Birchview Capital, LP held 138,000.00 shares of Travere Therapeutics Inc(TVTX), totaling $2.47 Mil. This investment constitutes 2.15% of their stock portfolio, and Birchview Capital, LP now holds 0.16% of the outstanding Travere Therapeutics Inc(TVTX) stock.

The initial trade took place in 2023Q1. And since then Birchview Capital, LP has made 5 purchases of TVTX, at an average price of $12.48, for a total of 296,000.00 shares. In addition, there have been 1 sales at an average price of $20.30 for 158,000.00 shares. Based on historical transaction data and TVTX's current price of $15.99, Birchview Capital, LP's estimated gain on his TVTX holdings is $1.72 Mil, reflecting a 46.55% gain to date.

Birchview Capital, LP TVTX ($15.99) Holding Chart

Birchview Capital, LP TVTX ($15.99) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1